JODIAN WILSON: Open Payments
NPI 1841777554 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $159 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $95 |
| Lilly USA, LLC | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| InSightec,Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: TZIELD, ZEPBOUND, Wegovy, Exablate, REXULTI, TRELEGY ELLIPTA, Ozempic, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
